The prognostic value of neutrophile/lymphocyte ratio and serum chemerin to predict maternal-fetal complications in pregnant systemic lupus erythematosus patients.
Gabriela MedinaFrancisco R González-CortésAntonio SánchezJuan G Vázquez-RodríguezIrvin Ordoñez-GonzálezMaría P Jiménez-ArellanoGrettel García-CollinotSusana I Morales-MontalvoOscar I Florez-DuranteMaría Del Pilar Cruz-DomínguezMaría F Colorado-CruzMiguel A Zurita-MuñozGilberto Cruz-ArteagaCarolina Sánchez-EnriquezLuis J JaraMiguel Ángel Saavedra-SalinasPublished in: Lupus (2023)
The NLR may help predict maternal-fetal complications in SLE pregnancy, constituting a marker of subclinical inflammation. Chemerin levels may be associated with preeclampsia. These biomarkers could improve the care of SLE patients with timely intervention of potential complications during pregnancy.
Keyphrases
- systemic lupus erythematosus
- pregnancy outcomes
- disease activity
- end stage renal disease
- risk factors
- ejection fraction
- randomized controlled trial
- pregnant women
- oxidative stress
- chronic kidney disease
- healthcare
- newly diagnosed
- birth weight
- prognostic factors
- palliative care
- early onset
- peritoneal dialysis
- rheumatoid arthritis
- quality improvement
- preterm birth
- patient reported outcomes
- body mass index
- pain management
- weight gain
- health insurance
- affordable care act